Patent · US Active

Method for measurement of vitamin D

US11415576B2 · kind B2 · utility

0Cited by

11References

14Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Elke Faatz · Huglfing, DE
Michael Gerg · Munich, DE
Hans-Peter Josel · Weilheim, DE
Christian Vogl · Gilching, DE

Key dates

Filing date	Jun 6, 2017
Grant date	Aug 16, 2022
Priority date	—
Expiry date	Mar 18, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/82
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention concerns an in vitro method for measurement of 25-hydroxyvitamin D, wherein the potentially interfering compound 24,25-dihydroxyvitamin D3 is blocked by a binding agent specifically binding to 24,25-dihydroxyvitamin D3 and not binding to 25-hydroxyvitamin D.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.